CTLA4（細胞傷害性Tリンパ球抗原4）阻害薬市場は2023年から2028年に22億3,000万米ドル、予測期間中のCAGRは15.11%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。CLTA4阻害薬の高い標的親和性と特異性、併用療法の人気の高まり、CLTA4阻害薬開発における戦略的提携などが市場を牽引しています。
本調査では、今後数年間のCTLA4（細胞傷害性Tリンパ球抗原4）阻害薬市場の成長を牽引する主な理由の1つとして、CLTA4の研究適応拡大を挙げています。また、CLTA4阻害薬の特効薬指定やがんに対する意識の高まりは、市場の大きな需要につながると見込まれています。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global CTLA4 (cytotoxic T-lymphocyte-associated protein 4) inhibitors market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global ctla4 (cytotoxic t-lymphocyte-associated protein 4) inhibitors market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Monotherapy - Market size and forecast 2023-2028
Exhibit 34: Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
6.4 Combination therapy - Market size and forecast 2023-2028
Exhibit 38: Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 52: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Agenus Inc.
Exhibit 111: Agenus Inc. - Overview
Exhibit 112: Agenus Inc. - Product / Service
Exhibit 113: Agenus Inc. - Key offerings
12.4 Akeso Inc.
Exhibit 114: Akeso Inc. - Overview
Exhibit 115: Akeso Inc. - Product / Service
Exhibit 116: Akeso Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 117: AstraZeneca Plc - Overview
Exhibit 118: AstraZeneca Plc - Product / Service
Exhibit 119: AstraZeneca Plc - Key news
Exhibit 120: AstraZeneca Plc - Key offerings
12.6 Bio Techne Corp.
Exhibit 121: Bio Techne Corp. - Overview
Exhibit 122: Bio Techne Corp. - Business segments
Exhibit 123: Bio Techne Corp. - Key offerings
Exhibit 124: Bio Techne Corp. - Segment focus
12.7 BioNTech SE
Exhibit 125: BioNTech SE - Overview
Exhibit 126: BioNTech SE - Key offerings
12.8 Bristol Myers Squibb Co.
Exhibit 127: Bristol Myers Squibb Co. - Overview
Exhibit 128: Bristol Myers Squibb Co. - Product / Service
Exhibit 129: Bristol Myers Squibb Co. - Key news
Exhibit 130: Bristol Myers Squibb Co. - Key offerings
12.9 HBM Holdings Ltd.
Exhibit 131: HBM Holdings Ltd. - Overview
Exhibit 132: HBM Holdings Ltd. - Product / Service
Exhibit 133: HBM Holdings Ltd. - Key offerings
12.10 Innovent Biologics Inc.
Exhibit 134: Innovent Biologics Inc. - Overview
Exhibit 135: Innovent Biologics Inc. - Product / Service
Exhibit 136: Innovent Biologics Inc. - Key offerings
12.11 Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Exhibit 137: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
Exhibit 138: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
Exhibit 139: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 140: Merck and Co. Inc. - Overview
Exhibit 141: Merck and Co. Inc. - Business segments
Exhibit 142: Merck and Co. Inc. - Key news
Exhibit 143: Merck and Co. Inc. - Key offerings
Exhibit 144: Merck and Co. Inc. - Segment focus
12.13 Ono Pharmaceutical Co. Ltd.
Exhibit 145: Ono Pharmaceutical Co. Ltd. - Overview
Exhibit 146: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibit 147: Ono Pharmaceutical Co. Ltd. - Key offerings
12.14 Shanghai Fosun Pharmaceutical Group Co. Ltd.
Exhibit 148: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Overview
Exhibit 149: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Business segments
Exhibit 150: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Key offerings
Exhibit 151: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Segment focus
12.15 TRACON Pharmaceuticals Inc.
Exhibit 152: TRACON Pharmaceuticals Inc. - Overview
Exhibit 153: TRACON Pharmaceuticals Inc. - Product / Service
Exhibit 154: TRACON Pharmaceuticals Inc. - Key offerings
12.16 Xencor Inc.
Exhibit 155: Xencor Inc. - Overview
Exhibit 156: Xencor Inc. - Product / Service
Exhibit 157: Xencor Inc. - Key news
Exhibit 158: Xencor Inc. - Key offerings
12.17 XILIO THERAPEUTICS INC.
Exhibit 159: XILIO THERAPEUTICS INC. - Overview
Exhibit 160: XILIO THERAPEUTICS INC. - Product / Service
Exhibit 161: XILIO THERAPEUTICS INC. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 162: Inclusions checklist
Exhibit 163: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 164: Currency conversion rates for US$
13.4 Research methodology
Exhibit 165: Research methodology
Exhibit 166: Validation techniques employed for market sizing
Exhibit 167: Information sources
13.5 List of abbreviations
Exhibit 168: List of abbreviations
